Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Sartorius AG VZO | 4 | 0 | 0 | 0 | €293.10 | - | - |
| Apellis Pharmaceuticals | 4 | 0 | 0 | 0 | €46.58 | €70.00 | 50.295% |
| Healthstream Inc. | 4 | 0 | 0 | 0 | €23.80 | €29.29 | 23.079% |
| Chemed Corp. | 4 | 0 | 0 | 0 | €530.00 | €588.14 | 10.970% |
| GSK plc ADR | 4 | 0 | 0 | 0 | €38.20 | €35.00 | -8.377% |
| Dr. Reddy's Laboratories Ltd. ADR | 5 | 1 | 1 | 0 | €69.00 | €73.92 | 7.130% |
| Eledon Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €1.85 | €12.09 | 553.481% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €5.75 | €19.86 | 245.477% |
| Galmed Pharmaceuticals Ltd. | 4 | 0 | 0 | 0 | €0.36 | €61.56 | 16811.841% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| XOMA Corp. | 4 | 0 | 2 | 0 | €23.60 | €68.62 | 190.764% |
| Vitrolife AB | 3 | 0 | 0 | 0 | €13.96 | - | - |
| Innoviva Inc. | 3 | 0 | 2 | 0 | €14.20 | €30.00 | 111.268% |
| Select Medical Holdings | 3 | 0 | 1 | 0 | €25.60 | €36.41 | 42.213% |
| Adverum Biotechnologies Inc. | 4 | 1 | 0 | 0 | €1.38 | €3.72 | 169.623% |
| Baxter International | 3 | 0 | 0 | 0 | €37.51 | €48.16 | 28.395% |
| Paul Hartmann AG | 3 | 0 | 0 | 0 | €205.00 | - | - |
| Immunic Inc. | 6 | 3 | 1 | 3 | €1.16 | €5.48 | 372.569% |
| Viking Therapeutics Inc | 4 | 1 | 1 | 1 | €69.98 | €100.00 | 42.898% |
| Bausch Health Companies Inc. | 3 | 0 | 1 | 0 | €8.06 | €16.47 | 104.294% |
| Perrigo Co. plc | 3 | 0 | 1 | 0 | €30.36 | €35.99 | 18.529% |
| Lightpath Techs A | 3 | 0 | 0 | 0 | €1.33 | €2.78 | 109.293% |
| Heidelberg Pharma AG | 3 | 0 | 0 | 0 | €3.00 | - | - |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €87.50 | €124.85 | 42.683% |
| Drägerwerk AG & Co. KGaA VZO | 3 | 0 | 1 | 0 | €50.80 | €57.50 | 13.189% |